PCAC is FDA's Pharmacy Compounding Advisory Committee. Its July 2026 meeting put seven peptides and the Section 503A Bulks List at the center of the national compounding debate.
PCAC became one of the biggest stories in peptides on July 23, 2026. BPC-157, KPV, and TB-500 all won favorable committee votes, with more peptide decisions scheduled across the two-day meeting.
Here is what PCAC is, what it voted on, and why this meeting matters for peptide compounding.
What does PCAC stand for?
PCAC stands for Pharmacy Compounding Advisory Committee. FDA brings the committee together to discuss scientific, medical, and compounding questions tied to federal pharmacy policy.
For the July 23–24, 2026 meeting, PCAC's central question is whether nominated peptide bulk drug substances should be included on the Section 503A Bulks List.
Why is PCAC voting on peptides?
The Section 503A Bulks List identifies bulk drug substances that can be used in qualifying patient-specific compounded prescriptions under the federal framework.
FDA scheduled 14 peptide questions for the July meeting: a free-base and acetate question for each of seven peptides.
- BPC-157
- KPV
- TB-500
- MOTS-c
- Emideltide, also called DSIP
- Epitalon
- Semax
The first July 2026 PCAC peptide results
Day 1 immediately produced major results:
- BPC-157 free base: favorable, 8 yes / 6 no / 1 abstention
- BPC-157 acetate: favorable, 8 yes / 6 no / 1 abstention
- KPV: favorable recommendation
- TB-500: favorable, 8 yes / 6 no / 1 abstention
The votes put peptide compounding into the national spotlight and built momentum for a regulated 503A route.
Why this PCAC meeting is so important
The meeting brings three forces into the same room: scientific evidence, years of real-world compounding experience, and strong patient demand for peptides.
Dr. Alex Tatem presented data covering more than 16 million doses of BPC-157 and nearly 190,000 vials containing TB-500. Those numbers gave the committee a direct view of the scale already present outside traditional drug-development datasets.
Read the dedicated stories on the 16 million-dose BPC-157 testimony and Dr. Tatem's TB-500 case.
PCAC live stream, schedule, and replay
FDA streams both meeting days free on YouTube. The same official links provide the PCAC webcast replay after each livestream ends:
Rebody's live PCAC peptide vote tracker keeps both webcasts, every peptide, and the latest vote totals in one place.
PCAC FAQ
What does PCAC stand for?
PCAC stands for Pharmacy Compounding Advisory Committee.
Which peptides are in the July 2026 PCAC meeting?
BPC-157, KPV, TB-500, MOTS-c, emideltide or DSIP, Epitalon, and Semax.
Where can I watch PCAC?
FDA streams the meeting on YouTube. Rebody's live tracker links directly to both official webcasts.